nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—multiple sclerosis	0.449	1	CpDpCtD
Sumatriptan—ABCG2—Cladribine—multiple sclerosis	0.044	0.144	CbGbCtD
Sumatriptan—SLCO1A2—Prednisolone—multiple sclerosis	0.0376	0.124	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—multiple sclerosis	0.0355	0.117	CbGbCtD
Sumatriptan—ABCG2—Mitoxantrone—multiple sclerosis	0.0321	0.105	CbGbCtD
Sumatriptan—SLCO1A2—Dexamethasone—multiple sclerosis	0.0222	0.0729	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—multiple sclerosis	0.0178	0.0586	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—multiple sclerosis	0.0168	0.0553	CbGbCtD
Sumatriptan—ABCG2—Dexamethasone—multiple sclerosis	0.0166	0.0546	CbGbCtD
Sumatriptan—ABCB1—Methylprednisolone—multiple sclerosis	0.0159	0.0521	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—multiple sclerosis	0.0134	0.0439	CbGbCtD
Sumatriptan—HTR1B—trigeminal nucleus—multiple sclerosis	0.0131	0.162	CbGeAlD
Sumatriptan—HTR1D—trigeminal nucleus—multiple sclerosis	0.0127	0.157	CbGeAlD
Sumatriptan—ABCB1—Mitoxantrone—multiple sclerosis	0.0116	0.038	CbGbCtD
Sumatriptan—HTR3A—area postrema—multiple sclerosis	0.0115	0.142	CbGeAlD
Sumatriptan—ABCB1—Betamethasone—multiple sclerosis	0.0103	0.0339	CbGbCtD
Sumatriptan—ABCB1—Prednisolone—multiple sclerosis	0.0102	0.0334	CbGbCtD
Sumatriptan—ABCB1—Prednisone—multiple sclerosis	0.00961	0.0316	CbGbCtD
Sumatriptan—HTR1D—meninx—multiple sclerosis	0.00844	0.104	CbGeAlD
Sumatriptan—HTR1F—trigeminal nerve—multiple sclerosis	0.00842	0.104	CbGeAlD
Sumatriptan—ABCB1—Dexamethasone—multiple sclerosis	0.006	0.0197	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—multiple sclerosis	0.00482	0.0158	CbGbCtD
Sumatriptan—HTR1B—trigeminal nerve—multiple sclerosis	0.00345	0.0425	CbGeAlD
Sumatriptan—HTR1D—trigeminal nerve—multiple sclerosis	0.00334	0.0411	CbGeAlD
Sumatriptan—HTR3A—nerve—multiple sclerosis	0.0015	0.0185	CbGeAlD
Sumatriptan—MAOA—nerve—multiple sclerosis	0.000928	0.0114	CbGeAlD
Sumatriptan—DRD2—nerve—multiple sclerosis	0.000918	0.0113	CbGeAlD
Sumatriptan—HTR1F—nervous system—multiple sclerosis	0.000691	0.00852	CbGeAlD
Sumatriptan—HTR1F—central nervous system—multiple sclerosis	0.000666	0.0082	CbGeAlD
Sumatriptan—HTR3A—brainstem—multiple sclerosis	0.000644	0.00794	CbGeAlD
Sumatriptan—HTR1B—brainstem—multiple sclerosis	0.000541	0.00666	CbGeAlD
Sumatriptan—HTR1F—brain—multiple sclerosis	0.000528	0.00651	CbGeAlD
Sumatriptan—HTR1D—brainstem—multiple sclerosis	0.000523	0.00645	CbGeAlD
Sumatriptan—HTR1A—brainstem—multiple sclerosis	0.000436	0.00538	CbGeAlD
Sumatriptan—MAOA—brainstem—multiple sclerosis	0.000399	0.00491	CbGeAlD
Sumatriptan—DRD2—brainstem—multiple sclerosis	0.000394	0.00486	CbGeAlD
Sumatriptan—MAOA—retina—multiple sclerosis	0.000385	0.00474	CbGeAlD
Sumatriptan—DRD2—retina—multiple sclerosis	0.00038	0.00469	CbGeAlD
Sumatriptan—SLCO1A2—medulla oblongata—multiple sclerosis	0.000355	0.00437	CbGeAlD
Sumatriptan—HTR1B—midbrain—multiple sclerosis	0.000345	0.00425	CbGeAlD
Sumatriptan—HTR3A—nervous system—multiple sclerosis	0.000338	0.00416	CbGeAlD
Sumatriptan—HTR1B—spinal cord—multiple sclerosis	0.000336	0.00414	CbGeAlD
Sumatriptan—HTR1D—midbrain—multiple sclerosis	0.000334	0.00411	CbGeAlD
Sumatriptan—HTR3A—central nervous system—multiple sclerosis	0.000325	0.00401	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—multiple sclerosis	0.000324	0.00399	CbGeAlD
Sumatriptan—SLCO1A2—spinal cord—multiple sclerosis	0.000316	0.0039	CbGeAlD
Sumatriptan—HTR1B—nervous system—multiple sclerosis	0.000283	0.00349	CbGeAlD
Sumatriptan—HTR1A—midbrain—multiple sclerosis	0.000278	0.00343	CbGeAlD
Sumatriptan—MAOA—medulla oblongata—multiple sclerosis	0.000278	0.00342	CbGeAlD
Sumatriptan—HTR1D—nervous system—multiple sclerosis	0.000274	0.00338	CbGeAlD
Sumatriptan—HTR1B—central nervous system—multiple sclerosis	0.000273	0.00336	CbGeAlD
Sumatriptan—HTR1A—spinal cord—multiple sclerosis	0.000271	0.00334	CbGeAlD
Sumatriptan—SLCO1A2—nervous system—multiple sclerosis	0.000266	0.00328	CbGeAlD
Sumatriptan—HTR1D—central nervous system—multiple sclerosis	0.000264	0.00325	CbGeAlD
Sumatriptan—HTR3A—brain—multiple sclerosis	0.000258	0.00318	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—multiple sclerosis	0.000257	0.00316	CbGeAlD
Sumatriptan—MAOA—midbrain—multiple sclerosis	0.000254	0.00313	CbGeAlD
Sumatriptan—DRD2—midbrain—multiple sclerosis	0.000251	0.0031	CbGeAlD
Sumatriptan—SLCO1A2—cerebellum—multiple sclerosis	0.000251	0.00309	CbGeAlD
Sumatriptan—MAOA—spinal cord—multiple sclerosis	0.000248	0.00305	CbGeAlD
Sumatriptan—ABCG2—medulla oblongata—multiple sclerosis	0.000241	0.00297	CbGeAlD
Sumatriptan—HTR1A—nervous system—multiple sclerosis	0.000229	0.00282	CbGeAlD
Sumatriptan—ABCG2—midbrain—multiple sclerosis	0.00022	0.00271	CbGeAlD
Sumatriptan—HTR1A—central nervous system—multiple sclerosis	0.00022	0.00271	CbGeAlD
Sumatriptan—HTR1B—brain—multiple sclerosis	0.000217	0.00267	CbGeAlD
Sumatriptan—HTR1A—cerebellum—multiple sclerosis	0.000215	0.00265	CbGeAlD
Sumatriptan—ABCG2—spinal cord—multiple sclerosis	0.000215	0.00265	CbGeAlD
Sumatriptan—HTR1D—brain—multiple sclerosis	0.00021	0.00258	CbGeAlD
Sumatriptan—MAOA—nervous system—multiple sclerosis	0.000209	0.00257	CbGeAlD
Sumatriptan—DRD2—nervous system—multiple sclerosis	0.000207	0.00254	CbGeAlD
Sumatriptan—SLCO1A2—brain—multiple sclerosis	0.000204	0.00251	CbGeAlD
Sumatriptan—MAOA—central nervous system—multiple sclerosis	0.000201	0.00248	CbGeAlD
Sumatriptan—DRD2—central nervous system—multiple sclerosis	0.000199	0.00245	CbGeAlD
Sumatriptan—MAOA—cerebellum—multiple sclerosis	0.000197	0.00242	CbGeAlD
Sumatriptan—DRD2—cerebellum—multiple sclerosis	0.000194	0.00239	CbGeAlD
Sumatriptan—HTR1A—brain—multiple sclerosis	0.000175	0.00215	CbGeAlD
Sumatriptan—ABCG2—cerebellum—multiple sclerosis	0.00017	0.0021	CbGeAlD
Sumatriptan—ABCB1—retina—multiple sclerosis	0.000164	0.00203	CbGeAlD
Sumatriptan—MAOA—brain—multiple sclerosis	0.00016	0.00197	CbGeAlD
Sumatriptan—DRD2—brain—multiple sclerosis	0.000158	0.00195	CbGeAlD
Sumatriptan—ABCG2—brain—multiple sclerosis	0.000138	0.00171	CbGeAlD
Sumatriptan—ABCB1—medulla oblongata—multiple sclerosis	0.000119	0.00146	CbGeAlD
Sumatriptan—ABCB1—midbrain—multiple sclerosis	0.000109	0.00134	CbGeAlD
Sumatriptan—ABCB1—spinal cord—multiple sclerosis	0.000106	0.00131	CbGeAlD
Sumatriptan—ABCB1—nervous system—multiple sclerosis	8.93e-05	0.0011	CbGeAlD
Sumatriptan—ABCB1—central nervous system—multiple sclerosis	8.59e-05	0.00106	CbGeAlD
Sumatriptan—ABCB1—cerebellum—multiple sclerosis	8.4e-05	0.00104	CbGeAlD
Sumatriptan—ABCB1—brain—multiple sclerosis	6.82e-05	0.000841	CbGeAlD
Sumatriptan—Dry mouth—Triamcinolone—multiple sclerosis	5.49e-05	0.000424	CcSEcCtD
Sumatriptan—Angioedema—Dexamethasone—multiple sclerosis	5.47e-05	0.000422	CcSEcCtD
Sumatriptan—Angioedema—Betamethasone—multiple sclerosis	5.47e-05	0.000422	CcSEcCtD
Sumatriptan—Angiopathy—Prednisone—multiple sclerosis	5.43e-05	0.000419	CcSEcCtD
Sumatriptan—Conjunctivitis—Methotrexate—multiple sclerosis	5.42e-05	0.000418	CcSEcCtD
Sumatriptan—Confusional state—Methylprednisolone—multiple sclerosis	5.42e-05	0.000418	CcSEcCtD
Sumatriptan—Immune system disorder—Prednisone—multiple sclerosis	5.41e-05	0.000417	CcSEcCtD
Sumatriptan—Malaise—Dexamethasone—multiple sclerosis	5.4e-05	0.000416	CcSEcCtD
Sumatriptan—Malaise—Betamethasone—multiple sclerosis	5.4e-05	0.000416	CcSEcCtD
Sumatriptan—Oedema—Triamcinolone—multiple sclerosis	5.38e-05	0.000415	CcSEcCtD
Sumatriptan—Anaphylactic shock—Triamcinolone—multiple sclerosis	5.38e-05	0.000415	CcSEcCtD
Sumatriptan—Vertigo—Dexamethasone—multiple sclerosis	5.38e-05	0.000415	CcSEcCtD
Sumatriptan—Vertigo—Betamethasone—multiple sclerosis	5.38e-05	0.000415	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	5.37e-05	0.000414	CcSEcCtD
Sumatriptan—Syncope—Dexamethasone—multiple sclerosis	5.37e-05	0.000414	CcSEcCtD
Sumatriptan—Syncope—Betamethasone—multiple sclerosis	5.37e-05	0.000414	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisone—multiple sclerosis	5.35e-05	0.000413	CcSEcCtD
Sumatriptan—Infection—Triamcinolone—multiple sclerosis	5.35e-05	0.000413	CcSEcCtD
Sumatriptan—Sweating—Methotrexate—multiple sclerosis	5.34e-05	0.000412	CcSEcCtD
Sumatriptan—Infection—Methylprednisolone—multiple sclerosis	5.34e-05	0.000412	CcSEcCtD
Sumatriptan—Haematuria—Methotrexate—multiple sclerosis	5.31e-05	0.00041	CcSEcCtD
Sumatriptan—Shock—Triamcinolone—multiple sclerosis	5.3e-05	0.000409	CcSEcCtD
Sumatriptan—Shock—Methylprednisolone—multiple sclerosis	5.28e-05	0.000408	CcSEcCtD
Sumatriptan—Nervous system disorder—Methylprednisolone—multiple sclerosis	5.27e-05	0.000406	CcSEcCtD
Sumatriptan—Loss of consciousness—Betamethasone—multiple sclerosis	5.26e-05	0.000406	CcSEcCtD
Sumatriptan—Loss of consciousness—Dexamethasone—multiple sclerosis	5.26e-05	0.000406	CcSEcCtD
Sumatriptan—Epistaxis—Methotrexate—multiple sclerosis	5.26e-05	0.000406	CcSEcCtD
Sumatriptan—Hypersensitivity—Mitoxantrone—multiple sclerosis	5.26e-05	0.000406	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisolone—multiple sclerosis	5.26e-05	0.000405	CcSEcCtD
Sumatriptan—Tachycardia—Triamcinolone—multiple sclerosis	5.25e-05	0.000405	CcSEcCtD
Sumatriptan—Nausea—Azathioprine—multiple sclerosis	5.24e-05	0.000404	CcSEcCtD
Sumatriptan—Tachycardia—Methylprednisolone—multiple sclerosis	5.24e-05	0.000404	CcSEcCtD
Sumatriptan—Skin disorder—Methylprednisolone—multiple sclerosis	5.22e-05	0.000402	CcSEcCtD
Sumatriptan—Erythema—Prednisone—multiple sclerosis	5.21e-05	0.000402	CcSEcCtD
Sumatriptan—Hyperhidrosis—Triamcinolone—multiple sclerosis	5.2e-05	0.000401	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	5.19e-05	0.000401	CcSEcCtD
Sumatriptan—Convulsion—Dexamethasone—multiple sclerosis	5.18e-05	0.0004	CcSEcCtD
Sumatriptan—Convulsion—Betamethasone—multiple sclerosis	5.18e-05	0.0004	CcSEcCtD
Sumatriptan—Hypertension—Betamethasone—multiple sclerosis	5.17e-05	0.000399	CcSEcCtD
Sumatriptan—Hypertension—Dexamethasone—multiple sclerosis	5.17e-05	0.000399	CcSEcCtD
Sumatriptan—Asthenia—Mitoxantrone—multiple sclerosis	5.12e-05	0.000395	CcSEcCtD
Sumatriptan—Myalgia—Dexamethasone—multiple sclerosis	5.09e-05	0.000393	CcSEcCtD
Sumatriptan—Myalgia—Betamethasone—multiple sclerosis	5.09e-05	0.000393	CcSEcCtD
Sumatriptan—Anxiety—Dexamethasone—multiple sclerosis	5.08e-05	0.000392	CcSEcCtD
Sumatriptan—Anxiety—Betamethasone—multiple sclerosis	5.08e-05	0.000392	CcSEcCtD
Sumatriptan—Discomfort—Dexamethasone—multiple sclerosis	5.03e-05	0.000388	CcSEcCtD
Sumatriptan—Discomfort—Betamethasone—multiple sclerosis	5.03e-05	0.000388	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—multiple sclerosis	5.03e-05	0.000388	CcSEcCtD
Sumatriptan—Hypotension—Methylprednisolone—multiple sclerosis	5.02e-05	0.000387	CcSEcCtD
Sumatriptan—Pain—Prednisolone—multiple sclerosis	5.01e-05	0.000386	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—multiple sclerosis	5e-05	0.000386	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.9e-05	0.000378	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.89e-05	0.000377	CcSEcCtD
Sumatriptan—Anaphylactic shock—Betamethasone—multiple sclerosis	4.88e-05	0.000377	CcSEcCtD
Sumatriptan—Oedema—Dexamethasone—multiple sclerosis	4.88e-05	0.000377	CcSEcCtD
Sumatriptan—Anaphylactic shock—Dexamethasone—multiple sclerosis	4.88e-05	0.000377	CcSEcCtD
Sumatriptan—Oedema—Betamethasone—multiple sclerosis	4.88e-05	0.000377	CcSEcCtD
Sumatriptan—Diarrhoea—Mitoxantrone—multiple sclerosis	4.88e-05	0.000377	CcSEcCtD
Sumatriptan—Infection—Dexamethasone—multiple sclerosis	4.85e-05	0.000374	CcSEcCtD
Sumatriptan—Infection—Betamethasone—multiple sclerosis	4.85e-05	0.000374	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisone—multiple sclerosis	4.84e-05	0.000373	CcSEcCtD
Sumatriptan—Paraesthesia—Triamcinolone—multiple sclerosis	4.83e-05	0.000373	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisolone—multiple sclerosis	4.82e-05	0.000372	CcSEcCtD
Sumatriptan—Paraesthesia—Methylprednisolone—multiple sclerosis	4.82e-05	0.000372	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—multiple sclerosis	4.82e-05	0.000372	CcSEcCtD
Sumatriptan—Anaemia—Prednisone—multiple sclerosis	4.82e-05	0.000372	CcSEcCtD
Sumatriptan—Shock—Betamethasone—multiple sclerosis	4.8e-05	0.000371	CcSEcCtD
Sumatriptan—Shock—Dexamethasone—multiple sclerosis	4.8e-05	0.000371	CcSEcCtD
Sumatriptan—Dyspnoea—Triamcinolone—multiple sclerosis	4.8e-05	0.00037	CcSEcCtD
Sumatriptan—Nervous system disorder—Betamethasone—multiple sclerosis	4.79e-05	0.000369	CcSEcCtD
Sumatriptan—Nervous system disorder—Dexamethasone—multiple sclerosis	4.79e-05	0.000369	CcSEcCtD
Sumatriptan—Agitation—Prednisone—multiple sclerosis	4.79e-05	0.000369	CcSEcCtD
Sumatriptan—Thrombocytopenia—Betamethasone—multiple sclerosis	4.78e-05	0.000369	CcSEcCtD
Sumatriptan—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.78e-05	0.000369	CcSEcCtD
Sumatriptan—Tachycardia—Dexamethasone—multiple sclerosis	4.77e-05	0.000368	CcSEcCtD
Sumatriptan—Tachycardia—Betamethasone—multiple sclerosis	4.77e-05	0.000368	CcSEcCtD
Sumatriptan—Angioedema—Prednisone—multiple sclerosis	4.76e-05	0.000367	CcSEcCtD
Sumatriptan—Hyperhidrosis—Betamethasone—multiple sclerosis	4.72e-05	0.000364	CcSEcCtD
Sumatriptan—Hyperhidrosis—Dexamethasone—multiple sclerosis	4.72e-05	0.000364	CcSEcCtD
Sumatriptan—Malaise—Prednisone—multiple sclerosis	4.7e-05	0.000363	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—multiple sclerosis	4.68e-05	0.000361	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—multiple sclerosis	4.68e-05	0.000361	CcSEcCtD
Sumatriptan—Syncope—Prednisone—multiple sclerosis	4.67e-05	0.000361	CcSEcCtD
Sumatriptan—Tinnitus—Methotrexate—multiple sclerosis	4.66e-05	0.00036	CcSEcCtD
Sumatriptan—Urticaria—Prednisolone—multiple sclerosis	4.65e-05	0.000359	CcSEcCtD
Sumatriptan—Fatigue—Triamcinolone—multiple sclerosis	4.64e-05	0.000358	CcSEcCtD
Sumatriptan—Fatigue—Methylprednisolone—multiple sclerosis	4.63e-05	0.000357	CcSEcCtD
Sumatriptan—Pain—Triamcinolone—multiple sclerosis	4.6e-05	0.000355	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—multiple sclerosis	4.58e-05	0.000353	CcSEcCtD
Sumatriptan—Hypotension—Betamethasone—multiple sclerosis	4.56e-05	0.000352	CcSEcCtD
Sumatriptan—Hypotension—Dexamethasone—multiple sclerosis	4.56e-05	0.000352	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—multiple sclerosis	4.54e-05	0.00035	CcSEcCtD
Sumatriptan—Vomiting—Mitoxantrone—multiple sclerosis	4.54e-05	0.00035	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—multiple sclerosis	4.52e-05	0.000349	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—multiple sclerosis	4.52e-05	0.000348	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—multiple sclerosis	4.51e-05	0.000348	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—multiple sclerosis	4.5e-05	0.000347	CcSEcCtD
Sumatriptan—Rash—Mitoxantrone—multiple sclerosis	4.5e-05	0.000347	CcSEcCtD
Sumatriptan—Dermatitis—Mitoxantrone—multiple sclerosis	4.49e-05	0.000347	CcSEcCtD
Sumatriptan—Chills—Methotrexate—multiple sclerosis	4.49e-05	0.000346	CcSEcCtD
Sumatriptan—Headache—Mitoxantrone—multiple sclerosis	4.47e-05	0.000345	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.45e-05	0.000343	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.45e-05	0.000343	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—multiple sclerosis	4.44e-05	0.000342	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—multiple sclerosis	4.44e-05	0.000342	CcSEcCtD
Sumatriptan—Feeling abnormal—Triamcinolone—multiple sclerosis	4.44e-05	0.000342	CcSEcCtD
Sumatriptan—Feeling abnormal—Methylprednisolone—multiple sclerosis	4.43e-05	0.000341	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—multiple sclerosis	4.42e-05	0.000341	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	4.39e-05	0.000339	CcSEcCtD
Sumatriptan—Paraesthesia—Betamethasone—multiple sclerosis	4.39e-05	0.000338	CcSEcCtD
Sumatriptan—Paraesthesia—Dexamethasone—multiple sclerosis	4.39e-05	0.000338	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—multiple sclerosis	4.38e-05	0.000338	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—multiple sclerosis	4.36e-05	0.000336	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisolone—multiple sclerosis	4.31e-05	0.000333	CcSEcCtD
Sumatriptan—Urticaria—Triamcinolone—multiple sclerosis	4.28e-05	0.00033	CcSEcCtD
Sumatriptan—Urticaria—Methylprednisolone—multiple sclerosis	4.27e-05	0.000329	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—multiple sclerosis	4.27e-05	0.000329	CcSEcCtD
Sumatriptan—Body temperature increased—Triamcinolone—multiple sclerosis	4.26e-05	0.000328	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—multiple sclerosis	4.25e-05	0.000328	CcSEcCtD
Sumatriptan—Oedema—Prednisone—multiple sclerosis	4.25e-05	0.000328	CcSEcCtD
Sumatriptan—Abdominal pain—Methylprednisolone—multiple sclerosis	4.25e-05	0.000328	CcSEcCtD
Sumatriptan—Decreased appetite—Betamethasone—multiple sclerosis	4.25e-05	0.000328	CcSEcCtD
Sumatriptan—Decreased appetite—Dexamethasone—multiple sclerosis	4.25e-05	0.000328	CcSEcCtD
Sumatriptan—Nausea—Mitoxantrone—multiple sclerosis	4.24e-05	0.000327	CcSEcCtD
Sumatriptan—Infection—Prednisone—multiple sclerosis	4.23e-05	0.000326	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.22e-05	0.000325	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.22e-05	0.000325	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—multiple sclerosis	4.21e-05	0.000325	CcSEcCtD
Sumatriptan—Fatigue—Dexamethasone—multiple sclerosis	4.21e-05	0.000325	CcSEcCtD
Sumatriptan—Fatigue—Betamethasone—multiple sclerosis	4.21e-05	0.000325	CcSEcCtD
Sumatriptan—Shock—Prednisone—multiple sclerosis	4.18e-05	0.000323	CcSEcCtD
Sumatriptan—Pain—Betamethasone—multiple sclerosis	4.18e-05	0.000322	CcSEcCtD
Sumatriptan—Pain—Dexamethasone—multiple sclerosis	4.18e-05	0.000322	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—multiple sclerosis	4.17e-05	0.000322	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—multiple sclerosis	4.15e-05	0.00032	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—multiple sclerosis	4.13e-05	0.000319	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—multiple sclerosis	4.11e-05	0.000317	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—multiple sclerosis	4.04e-05	0.000312	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—multiple sclerosis	4.03e-05	0.000311	CcSEcCtD
Sumatriptan—Feeling abnormal—Betamethasone—multiple sclerosis	4.02e-05	0.00031	CcSEcCtD
Sumatriptan—Feeling abnormal—Dexamethasone—multiple sclerosis	4.02e-05	0.00031	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.99e-05	0.000308	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.99e-05	0.000308	CcSEcCtD
Sumatriptan—Hypersensitivity—Triamcinolone—multiple sclerosis	3.97e-05	0.000306	CcSEcCtD
Sumatriptan—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.96e-05	0.000305	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—multiple sclerosis	3.93e-05	0.000303	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—multiple sclerosis	3.91e-05	0.000302	CcSEcCtD
Sumatriptan—Urticaria—Dexamethasone—multiple sclerosis	3.88e-05	0.000299	CcSEcCtD
Sumatriptan—Urticaria—Betamethasone—multiple sclerosis	3.88e-05	0.000299	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.88e-05	0.000299	CcSEcCtD
Sumatriptan—Dizziness—Prednisolone—multiple sclerosis	3.87e-05	0.000299	CcSEcCtD
Sumatriptan—Asthenia—Triamcinolone—multiple sclerosis	3.86e-05	0.000298	CcSEcCtD
Sumatriptan—Abdominal pain—Betamethasone—multiple sclerosis	3.86e-05	0.000298	CcSEcCtD
Sumatriptan—Abdominal pain—Dexamethasone—multiple sclerosis	3.86e-05	0.000298	CcSEcCtD
Sumatriptan—Body temperature increased—Dexamethasone—multiple sclerosis	3.86e-05	0.000298	CcSEcCtD
Sumatriptan—Body temperature increased—Betamethasone—multiple sclerosis	3.86e-05	0.000298	CcSEcCtD
Sumatriptan—Asthenia—Methylprednisolone—multiple sclerosis	3.85e-05	0.000297	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—multiple sclerosis	3.82e-05	0.000295	CcSEcCtD
Sumatriptan—Pruritus—Triamcinolone—multiple sclerosis	3.81e-05	0.000294	CcSEcCtD
Sumatriptan—Cough—Methotrexate—multiple sclerosis	3.8e-05	0.000293	CcSEcCtD
Sumatriptan—Pruritus—Methylprednisolone—multiple sclerosis	3.8e-05	0.000293	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—multiple sclerosis	3.77e-05	0.000291	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—multiple sclerosis	3.71e-05	0.000286	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—multiple sclerosis	3.71e-05	0.000286	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—multiple sclerosis	3.71e-05	0.000286	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—multiple sclerosis	3.7e-05	0.000285	CcSEcCtD
Sumatriptan—Rash—Prednisolone—multiple sclerosis	3.69e-05	0.000285	CcSEcCtD
Sumatriptan—Dermatitis—Prednisolone—multiple sclerosis	3.69e-05	0.000284	CcSEcCtD
Sumatriptan—Diarrhoea—Methylprednisolone—multiple sclerosis	3.67e-05	0.000283	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—multiple sclerosis	3.67e-05	0.000283	CcSEcCtD
Sumatriptan—Headache—Prednisolone—multiple sclerosis	3.67e-05	0.000283	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—multiple sclerosis	3.66e-05	0.000283	CcSEcCtD
Sumatriptan—Constipation—Prednisone—multiple sclerosis	3.64e-05	0.000281	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—multiple sclerosis	3.58e-05	0.000277	CcSEcCtD
Sumatriptan—Dizziness—Triamcinolone—multiple sclerosis	3.56e-05	0.000275	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—multiple sclerosis	3.55e-05	0.000274	CcSEcCtD
Sumatriptan—Dizziness—Methylprednisolone—multiple sclerosis	3.55e-05	0.000274	CcSEcCtD
Sumatriptan—Infection—Methotrexate—multiple sclerosis	3.53e-05	0.000272	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—multiple sclerosis	3.5e-05	0.00027	CcSEcCtD
Sumatriptan—Asthenia—Dexamethasone—multiple sclerosis	3.5e-05	0.00027	CcSEcCtD
Sumatriptan—Asthenia—Betamethasone—multiple sclerosis	3.5e-05	0.00027	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—multiple sclerosis	3.49e-05	0.000269	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—multiple sclerosis	3.48e-05	0.000268	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—multiple sclerosis	3.48e-05	0.000268	CcSEcCtD
Sumatriptan—Nausea—Prednisolone—multiple sclerosis	3.48e-05	0.000268	CcSEcCtD
Sumatriptan—Pruritus—Dexamethasone—multiple sclerosis	3.46e-05	0.000267	CcSEcCtD
Sumatriptan—Pruritus—Betamethasone—multiple sclerosis	3.46e-05	0.000267	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—multiple sclerosis	3.45e-05	0.000266	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—multiple sclerosis	3.44e-05	0.000265	CcSEcCtD
Sumatriptan—Vomiting—Triamcinolone—multiple sclerosis	3.42e-05	0.000264	CcSEcCtD
Sumatriptan—Vomiting—Methylprednisolone—multiple sclerosis	3.41e-05	0.000263	CcSEcCtD
Sumatriptan—Rash—Triamcinolone—multiple sclerosis	3.39e-05	0.000262	CcSEcCtD
Sumatriptan—Dermatitis—Triamcinolone—multiple sclerosis	3.39e-05	0.000262	CcSEcCtD
Sumatriptan—Rash—Methylprednisolone—multiple sclerosis	3.39e-05	0.000261	CcSEcCtD
Sumatriptan—Dermatitis—Methylprednisolone—multiple sclerosis	3.38e-05	0.000261	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—multiple sclerosis	3.38e-05	0.000261	CcSEcCtD
Sumatriptan—Headache—Triamcinolone—multiple sclerosis	3.37e-05	0.00026	CcSEcCtD
Sumatriptan—Headache—Methylprednisolone—multiple sclerosis	3.36e-05	0.00026	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—multiple sclerosis	3.36e-05	0.000259	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—multiple sclerosis	3.36e-05	0.000259	CcSEcCtD
Sumatriptan—Diarrhoea—Betamethasone—multiple sclerosis	3.34e-05	0.000258	CcSEcCtD
Sumatriptan—Diarrhoea—Dexamethasone—multiple sclerosis	3.34e-05	0.000258	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—multiple sclerosis	3.32e-05	0.000256	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.24e-05	0.00025	CcSEcCtD
Sumatriptan—Dizziness—Dexamethasone—multiple sclerosis	3.23e-05	0.000249	CcSEcCtD
Sumatriptan—Dizziness—Betamethasone—multiple sclerosis	3.23e-05	0.000249	CcSEcCtD
Sumatriptan—Nausea—Triamcinolone—multiple sclerosis	3.2e-05	0.000247	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—multiple sclerosis	3.19e-05	0.000246	CcSEcCtD
Sumatriptan—Nausea—Methylprednisolone—multiple sclerosis	3.19e-05	0.000246	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—multiple sclerosis	3.17e-05	0.000244	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—multiple sclerosis	3.16e-05	0.000244	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—multiple sclerosis	3.13e-05	0.000242	CcSEcCtD
Sumatriptan—Vomiting—Dexamethasone—multiple sclerosis	3.11e-05	0.00024	CcSEcCtD
Sumatriptan—Vomiting—Betamethasone—multiple sclerosis	3.11e-05	0.00024	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—multiple sclerosis	3.09e-05	0.000238	CcSEcCtD
Sumatriptan—Rash—Dexamethasone—multiple sclerosis	3.08e-05	0.000238	CcSEcCtD
Sumatriptan—Rash—Betamethasone—multiple sclerosis	3.08e-05	0.000238	CcSEcCtD
Sumatriptan—Dermatitis—Dexamethasone—multiple sclerosis	3.08e-05	0.000237	CcSEcCtD
Sumatriptan—Dermatitis—Betamethasone—multiple sclerosis	3.08e-05	0.000237	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.07e-05	0.000237	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—multiple sclerosis	3.06e-05	0.000236	CcSEcCtD
Sumatriptan—Headache—Betamethasone—multiple sclerosis	3.06e-05	0.000236	CcSEcCtD
Sumatriptan—Headache—Dexamethasone—multiple sclerosis	3.06e-05	0.000236	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—multiple sclerosis	3.05e-05	0.000235	CcSEcCtD
Sumatriptan—Pain—Methotrexate—multiple sclerosis	3.04e-05	0.000234	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—multiple sclerosis	3.01e-05	0.000232	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—multiple sclerosis	2.93e-05	0.000226	CcSEcCtD
Sumatriptan—Diarrhoea—Prednisone—multiple sclerosis	2.91e-05	0.000225	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.91e-05	0.000224	CcSEcCtD
Sumatriptan—Nausea—Dexamethasone—multiple sclerosis	2.9e-05	0.000224	CcSEcCtD
Sumatriptan—Nausea—Betamethasone—multiple sclerosis	2.9e-05	0.000224	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—multiple sclerosis	2.82e-05	0.000218	CcSEcCtD
Sumatriptan—Dizziness—Prednisone—multiple sclerosis	2.81e-05	0.000217	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—multiple sclerosis	2.81e-05	0.000217	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—multiple sclerosis	2.81e-05	0.000217	CcSEcCtD
Sumatriptan—Vomiting—Prednisone—multiple sclerosis	2.7e-05	0.000209	CcSEcCtD
Sumatriptan—Rash—Prednisone—multiple sclerosis	2.68e-05	0.000207	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—multiple sclerosis	2.68e-05	0.000207	CcSEcCtD
Sumatriptan—Headache—Prednisone—multiple sclerosis	2.66e-05	0.000206	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—multiple sclerosis	2.62e-05	0.000202	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—multiple sclerosis	2.55e-05	0.000197	CcSEcCtD
Sumatriptan—Nausea—Prednisone—multiple sclerosis	2.53e-05	0.000195	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—multiple sclerosis	2.51e-05	0.000194	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—multiple sclerosis	2.43e-05	0.000188	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—multiple sclerosis	2.35e-05	0.000181	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—multiple sclerosis	2.26e-05	0.000174	CcSEcCtD
Sumatriptan—Rash—Methotrexate—multiple sclerosis	2.24e-05	0.000173	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—multiple sclerosis	2.24e-05	0.000173	CcSEcCtD
Sumatriptan—Headache—Methotrexate—multiple sclerosis	2.23e-05	0.000172	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—multiple sclerosis	2.11e-05	0.000163	CcSEcCtD
Sumatriptan—HTR1D—GPCR downstream signaling—CCL5—multiple sclerosis	1.66e-05	0.000464	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—POMC—multiple sclerosis	1.66e-05	0.000464	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.64e-05	0.00046	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CCL5—multiple sclerosis	1.62e-05	0.000454	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CCL2—multiple sclerosis	1.62e-05	0.000454	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	1.61e-05	0.000452	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL10—multiple sclerosis	1.61e-05	0.000452	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	1.61e-05	0.000452	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	1.59e-05	0.000447	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.59e-05	0.000446	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.58e-05	0.000444	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	1.57e-05	0.000441	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	1.57e-05	0.00044	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	1.56e-05	0.000437	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	1.54e-05	0.000431	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.53e-05	0.00043	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	1.52e-05	0.000427	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	1.52e-05	0.000425	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	1.51e-05	0.000422	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCL5—multiple sclerosis	1.5e-05	0.000421	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CCR5—multiple sclerosis	1.49e-05	0.000418	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—MAPK1—multiple sclerosis	1.48e-05	0.000413	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCL5—multiple sclerosis	1.47e-05	0.000413	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—TYK2—multiple sclerosis	1.47e-05	0.000412	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2RA—multiple sclerosis	1.47e-05	0.000412	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	1.47e-05	0.000411	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CCR5—multiple sclerosis	1.46e-05	0.000409	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RGS1—multiple sclerosis	1.46e-05	0.000408	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.45e-05	0.000406	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	1.45e-05	0.000406	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	1.44e-05	0.000404	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	1.44e-05	0.000403	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	1.44e-05	0.000403	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	1.44e-05	0.000402	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	1.42e-05	0.000397	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CD86—multiple sclerosis	1.41e-05	0.000395	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	1.4e-05	0.000392	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCL5—multiple sclerosis	1.39e-05	0.000389	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GPR65—multiple sclerosis	1.38e-05	0.000387	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-05	0.000386	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	1.38e-05	0.000386	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL3—multiple sclerosis	1.37e-05	0.000385	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000384	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.36e-05	0.000381	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCR5—multiple sclerosis	1.36e-05	0.00038	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—POMC—multiple sclerosis	1.35e-05	0.000379	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.35e-05	0.000378	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.35e-05	0.000378	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—IL2—multiple sclerosis	1.35e-05	0.000378	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	1.35e-05	0.000377	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2RA—multiple sclerosis	1.34e-05	0.000374	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	1.33e-05	0.000372	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	1.32e-05	0.000371	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTGER4—multiple sclerosis	1.32e-05	0.000371	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	1.31e-05	0.000366	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	1.3e-05	0.000365	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PGR—multiple sclerosis	1.3e-05	0.000365	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	1.3e-05	0.000363	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SPP1—multiple sclerosis	1.29e-05	0.000361	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCR3—multiple sclerosis	1.28e-05	0.000358	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PGR—multiple sclerosis	1.28e-05	0.000357	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	1.27e-05	0.000356	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—BCHE—multiple sclerosis	1.27e-05	0.000356	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CD28—multiple sclerosis	1.27e-05	0.000354	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR1—multiple sclerosis	1.26e-05	0.000354	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	1.26e-05	0.000354	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.26e-05	0.000353	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCR5—multiple sclerosis	1.25e-05	0.000351	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	1.25e-05	0.00035	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR2—multiple sclerosis	1.24e-05	0.000348	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.24e-05	0.000348	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CD28—multiple sclerosis	1.24e-05	0.000347	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	1.24e-05	0.000346	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2RA—multiple sclerosis	1.23e-05	0.000346	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000346	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL2—multiple sclerosis	1.22e-05	0.000343	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	1.22e-05	0.000341	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.18e-05	0.00033	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000329	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—POMC—multiple sclerosis	1.17e-05	0.000327	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CNR1—multiple sclerosis	1.15e-05	0.000321	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	1.14e-05	0.000321	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	1.14e-05	0.00032	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APOE—multiple sclerosis	1.14e-05	0.000319	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	1.12e-05	0.000315	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	1.12e-05	0.000314	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.11e-05	0.000312	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	1.1e-05	0.000308	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.1e-05	0.000307	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.09e-05	0.000306	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—BCHE—multiple sclerosis	1.09e-05	0.000304	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	1.09e-05	0.000304	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—POMC—multiple sclerosis	1.06e-05	0.000297	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	1.04e-05	0.000291	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCL2—multiple sclerosis	1.04e-05	0.00029	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL10—multiple sclerosis	1.03e-05	0.000289	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CD80—multiple sclerosis	1.03e-05	0.000289	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	1.03e-05	0.000287	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000286	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	1.02e-05	0.000284	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	1.01e-05	0.000283	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	1.01e-05	0.000283	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	9.97e-06	0.000279	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	9.87e-06	0.000276	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	9.86e-06	0.000276	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—POMC—multiple sclerosis	9.79e-06	0.000274	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	9.78e-06	0.000274	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PGR—multiple sclerosis	9.72e-06	0.000272	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	9.64e-06	0.00027	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCL2—multiple sclerosis	9.58e-06	0.000268	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	9.53e-06	0.000267	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD28—multiple sclerosis	9.44e-06	0.000264	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.43e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	9.41e-06	0.000264	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.41e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—MAPK1—multiple sclerosis	9.37e-06	0.000262	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	9.27e-06	0.00026	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.23e-06	0.000258	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	9.22e-06	0.000258	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CD86—multiple sclerosis	9.03e-06	0.000253	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL3—multiple sclerosis	9e-06	0.000252	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	8.89e-06	0.000249	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	8.88e-06	0.000249	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CD86—multiple sclerosis	8.84e-06	0.000248	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.79e-06	0.000246	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	8.75e-06	0.000245	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	8.7e-06	0.000244	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	8.7e-06	0.000244	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TYK2—multiple sclerosis	8.7e-06	0.000244	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	8.66e-06	0.000243	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	8.63e-06	0.000242	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	8.56e-06	0.00024	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PGR—multiple sclerosis	8.53e-06	0.000239	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	8.45e-06	0.000237	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	8.37e-06	0.000234	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD28—multiple sclerosis	8.29e-06	0.000232	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—multiple sclerosis	8.25e-06	0.000231	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	8.23e-06	0.000231	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR2—multiple sclerosis	8.14e-06	0.000228	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	8.06e-06	0.000226	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	8.01e-06	0.000224	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	7.9e-06	0.000221	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	7.89e-06	0.000221	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	7.84e-06	0.00022	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	7.83e-06	0.000219	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	7.73e-06	0.000217	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	7.73e-06	0.000216	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	7.7e-06	0.000216	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	7.67e-06	0.000215	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—multiple sclerosis	7.65e-06	0.000214	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	7.64e-06	0.000214	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CNR1—multiple sclerosis	7.51e-06	0.00021	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—multiple sclerosis	7.29e-06	0.000204	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—multiple sclerosis	7.24e-06	0.000203	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—multiple sclerosis	7.2e-06	0.000202	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—multiple sclerosis	7.13e-06	0.0002	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—multiple sclerosis	7.09e-06	0.000199	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—multiple sclerosis	7.06e-06	0.000198	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	7.02e-06	0.000197	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—multiple sclerosis	6.94e-06	0.000194	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—multiple sclerosis	6.85e-06	0.000192	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	6.79e-06	0.00019	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	6.76e-06	0.000189	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD86—multiple sclerosis	6.74e-06	0.000189	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	6.63e-06	0.000186	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CD80—multiple sclerosis	6.59e-06	0.000185	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—multiple sclerosis	6.57e-06	0.000184	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—multiple sclerosis	6.53e-06	0.000183	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—multiple sclerosis	6.46e-06	0.000181	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CD80—multiple sclerosis	6.45e-06	0.000181	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	6.43e-06	0.00018	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—multiple sclerosis	6.26e-06	0.000175	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	6.17e-06	0.000173	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	6.14e-06	0.000172	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—multiple sclerosis	6.13e-06	0.000172	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	6.12e-06	0.000172	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—multiple sclerosis	6.09e-06	0.000171	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—multiple sclerosis	6.06e-06	0.00017	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	6e-06	0.000168	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	5.99e-06	0.000168	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—multiple sclerosis	5.99e-06	0.000168	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	5.97e-06	0.000167	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD86—multiple sclerosis	5.91e-06	0.000166	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.91e-06	0.000165	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	5.89e-06	0.000165	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—BCHE—multiple sclerosis	5.87e-06	0.000164	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	5.87e-06	0.000164	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	5.84e-06	0.000164	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL5—multiple sclerosis	5.82e-06	0.000163	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—multiple sclerosis	5.66e-06	0.000158	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	5.65e-06	0.000158	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	5.64e-06	0.000158	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—multiple sclerosis	5.61e-06	0.000157	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	5.56e-06	0.000156	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	5.54e-06	0.000155	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—multiple sclerosis	5.53e-06	0.000155	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	5.45e-06	0.000153	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—multiple sclerosis	5.43e-06	0.000152	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SPP1—multiple sclerosis	5.39e-06	0.000151	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR5—multiple sclerosis	5.24e-06	0.000147	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	5.17e-06	0.000145	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—multiple sclerosis	5.13e-06	0.000144	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—multiple sclerosis	5.12e-06	0.000143	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD80—multiple sclerosis	4.91e-06	0.000138	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—multiple sclerosis	4.77e-06	0.000134	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—multiple sclerosis	4.67e-06	0.000131	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—multiple sclerosis	4.63e-06	0.00013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	4.6e-06	0.000129	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	4.57e-06	0.000128	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—multiple sclerosis	4.53e-06	0.000127	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	4.51e-06	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.47e-06	0.000125	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	4.38e-06	0.000123	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD80—multiple sclerosis	4.31e-06	0.000121	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	4.29e-06	0.00012	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—multiple sclerosis	4.25e-06	0.000119	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	4.15e-06	0.000116	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—multiple sclerosis	4.1e-06	0.000115	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—multiple sclerosis	4.01e-06	0.000112	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	3.92e-06	0.00011	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	3.89e-06	0.000109	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	3.81e-06	0.000107	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TYK2—multiple sclerosis	3.64e-06	0.000102	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—multiple sclerosis	3.62e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	3.61e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—multiple sclerosis	3.54e-06	9.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	3.54e-06	9.91e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	3.53e-06	9.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—multiple sclerosis	3.53e-06	9.89e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	3.47e-06	9.71e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—multiple sclerosis	3.45e-06	9.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	3.43e-06	9.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	3.27e-06	9.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—multiple sclerosis	3.03e-06	8.5e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—multiple sclerosis	3.03e-06	8.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—multiple sclerosis	3.02e-06	8.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	2.9e-06	8.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—multiple sclerosis	2.87e-06	8.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—multiple sclerosis	2.77e-06	7.75e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—multiple sclerosis	2.72e-06	7.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—multiple sclerosis	2.7e-06	7.56e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	2.69e-06	7.54e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—multiple sclerosis	2.66e-06	7.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	2.64e-06	7.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—multiple sclerosis	2.55e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—multiple sclerosis	2.37e-06	6.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	2.36e-06	6.62e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	2.32e-06	6.49e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—multiple sclerosis	2.03e-06	5.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—multiple sclerosis	1.78e-06	4.99e-05	CbGpPWpGaD
